Synthesis of the Bycroft-Gowland structure of micrococcin P1

Organic Letters

Volumn 1, Issue 11, 1999, Pages 1843-1846

  Ciufolini, Marco A ^a   Shen, Yong Chun ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; ANTINEOPLASTIC ANTIBIOTIC; BACTERIOCIN; MICROCOCCIN; PEPTIDE;

ARTICLE; CHEMISTRY; HYDROLYSIS; STREPTOMYCES; SYNTHESIS;

ANTI-BACTERIAL AGENTS; ANTIBIOTICS, ANTINEOPLASTIC; BACTERIOCINS; HYDROLYSIS; PEPTIDES; STREPTOMYCES;

EID: 0033518045     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol991115e     Document Type: Article

References (37)

1. Isolation from Bacillus pumilus: Fuller, A. T. Nature 1955, 175, 722. Micrococcin P is very similar, possibly identical, to an antibiotic isolated from a Micrococcus species and named "micrococcin" by: Su, T. L. Brit. J. Exp. Path. 1948, 29, 473. No structural work on the Su micrococcin appears to have been described in the literature.
2. Isolation from Bacillus pumilus: Fuller, A. T. Nature 1955, 175, 722. Micrococcin P is very similar, possibly identical, to an antibiotic isolated from a Micrococcus species and named "micrococcin" by: Su, T. L. Brit. J. Exp. Path. 1948, 29, 473. No structural work on the Su micrococcin appears to have been described in the literature.
3. (a) Rosendahl, G.; Douthwaite, S. Nucl. Acids Res. 1994, 22, 357.
4. (b) Cundliffe, E.; Thompson, C. J. Eur. J. Biochem. 1981, 118, 47.
5. Review: Pestka, S. In Antibiotics; Corcoran, J. W.; Hahn, F. E., Eds.: Springer-Verlag: New York, 1975; Vol. 3, p 480 ff.
6. Mijovic, M. P. V.; Walker, J. J. Chem. Soc. 1960, 909.
7. The side chain amino alcohol was originally assigned as alaninol (ref 4) and later ascertained to be isoalaninol (ref 6). In either case, the levo isomer is the one of D-(R)-configuration: Klyne, W. Buckingham, J. Atlas of Stereochemistry: Absolute Configurations of Organic Molecules, 2nd ed.; Oxford University Press: New York, 1978.
8. (a) Walker, J.; Olesker, A.; Valente, L.; Rabanal, R.; Lukacs, G. J. Chem. Soc., Chem. Commun. 1977, 706.
9. (b) Reference 6a, p 708, top of the page.
10. Bycroft, B. W.; Gowland, M. S. J. Chem. Soc., Chem. Commun. 1978, 256.
11. (a) Nakamura, Y.; Shin, C.-G.; Umemura, K.; Yoshimura, J. Chem. Lett. 1992, 1005.
12. (b) Okumura, K.; Shigekuni, M.; Nakamura, Y.; Shin, C.-G. Chem. Lett. 1996, 1025.
13. (a) Murakami, T.; Holt, T. G.; Thompson, C. T. J. Bacteriol. 1989, 171, 1459.
14. (b) Holmes, D. G.; Caso, J. L.; Thompson, C. T. EMBO J. 1993, 8, 3183.
15. (c) Yun, B.-S.; Hidaka, T.; Furihata, K.; Seto, H. J. Antibiot. 1994, 47, 510.
16. E.g.: (a) McConkey, G. A.; Gogers, M. J.; McCutchan, T. F. J. Biol. Chem. 1997, 272, 2046.
17. (b) Clough, B.; Strath, M.; Preiser, P.; Denny, P.; Wilson, I. FEBS Lett. 1997, 406, 123.
18. (c) Chiu, M. L.; Folcher, M.; Griffin, P.; Holt, T.; Klatt, T.; Thompson, C. J. Biochemistry 1996, 35, 2332.
19. (d) Lu, M.; Draper, D. E. Nucleic Acids Res. 1995, 23, 3426.
20. (e) Rosendahl, G.; Douthwaite, S. J. Mol. Biol. 1993, 234, 1013.
21. (f) Egebjerg, J.; Douthwaite, S. R.; Liljas, A.; Garrett, R. A. J. Mol. Biol. 1990, 213, 275 and references therein.
22. For pioneering work in this area, see: Kelly, T. R.; Jagoe, C. T.; Gu, Z. Tetrahedron Lett. 1991, 32, 4263 as well as rets 8 and 13.
23. Ciufolini, M. A.; Shen, Y.-C. J. Org. Chem. 1997, 62, 3804.
24. Shin, C.-G.; Okamura, K.; Shigekuni, M.; Nakamura, Y. Chem. Lett. 1998, 139.
25. Okamura, K.; Ito, A.; Yoshioka, D.; Shin, C.-G. Heterocycles 1998, 48, 1319.
26. A route to an intermediate differing from 3 only at the level of protecting groups has been described (ref 8a), but the present objectives proved to be better served by an alternative avenue to that fragment. The merger of 3 and 4 was best conducted by contributing the pyridine-thiazole cluster as compound 14 (ref 13), by having the short side chain already present on the pyridine-thiazole array during macrocyclization; by forming the bonds between 3 and 4 in the order a first and then b, by introducing dehydroamino acid units as threonines to be dehydrated at a well-defined stage; and by performing the macrocyclization via an acyl azide.
27. E.g.: (a) Favara, D.; Omodei-Sale; A.; Consonni, P.; Depaoli, A. Tetrahedron Lett. 1982, 23, 3105.
28. (b) Garner, P. Tetrahedron Lett. 1984, 25, 5855.
29. (a) Flynn, D. L.; Zelle, R. E.; Grieco, P. A. J. Org. Chem. 1983, 48, 2424.
30. (b) Ishizuka, T.; Kunieda, T. Tetrahedron Lett. 1987, 28, 4185.
31. Aguilar, E.; Meyers, A. I. Tetrahedron Lett. 1994, 35, 2473. Application of this protocol was essential to suppress racemization of 10.
32. Attenburrow, J.; Cameron, A. F. B.; Chapman, J. H.; Evans, R. M.; Hems, B. A.; Jansen, A. B. A.; Walker, T. J. Chem. Soc. 1952, 1094.
33. Cf. Kraus, G. A.; Taschner, M. J. J. Org. Chem. 1980, 45, 1175.
34. 2 group to the mesylate backside.
35. Ascertained by X-ray crystallography: James, M. N. G.; Watson, K. J. J. Chem. Soc. C 1966, 1361.
36. Dean, B. M.; Mijovic, M. P. V.; Walker, J. J. Chem. Soc. 1961, 3394.
37. Brookes, P.; Fuller, A. T.; Walker, J. J. Chem. Soc. 1957, 689.